Latest news
Antibody-drug conjugate shows promising early results in phase I trial in sarcoma patients
Antibody-drug conjugate shows promising early results in phase I trial in sarcoma patients 19 November Barcelona, Spain: An antibody-drug conjugate, a type of drug that targets and enters cancer cells like a [...]
New drug IACS-6274 shows promise in phase I clinical trial treating patients with advanced ovarian cancer
New drug IACS-6274 shows promise in phase I clinical trial treating patients with advanced ovarian cancer 19 November, Barcelona, Spain: Patients with advanced, hard-to-treat ovarian cancer have responded well to treatment [...]
Antibody-drug conjugate designed to target tumour ‘scaffolding’ produces positive results
Antibody-drug conjugate designed to target tumour ‘scaffolding’ produces positive results in phase I head and neck cancer trial 19 November, Barcelona, Spain: An antibody-drug conjugate (ADC), called micvotabart pelidotin, or MICVO, [...]
